Activation of Renal Vascular Smooth Muscle TRPV4 Channels by 5-hydroxytryptamine Impairs Kidney Function in Neonatal Pigs
Overview
Authors
Affiliations
Control of microvascular reactivity by 5-hydroxytryptamine (5-HT; serotonin) is complex and may depend on vascular bed type and 5-HT receptors. 5-HT receptors consist of seven families (5-HT-5-HT), with 5-HT predominantly mediating renal vasoconstriction. Cyclooxygenase (COX) and smooth muscle intracellular Ca levels ([Ca]) have been implicated in 5-HT-induced vascular reactivity. Although 5-HT receptor expression and circulating 5-HT levels are known to be dependent on postnatal age, control of neonatal renal microvascular function by 5-HT is unclear. In the present study, we demonstrate that 5-HT stimulated human TRPV4 transiently expressed in Chinese hamster ovary cells. 5-HT is the predominant 5-HT receptor subtype in freshly isolated neonatal pig renal microvascular smooth muscle cells (SMCs). HC-067047 (HC), a selective TRPV4 blocker, attenuated cation currents induced by 5-HT in the SMCs. HC also inhibited the 5-HT-induced increase in renal microvascular [Ca] and constriction. Intrarenal artery infusion of 5-HT had minimal effects on systemic hemodynamics but reduced renal blood flow (RBF) and increased renal vascular resistance (RVR) in the pigs. Transdermal measurement of glomerular filtration rate (GFR) indicated that kidney infusion of 5-HT reduced GFR. HC and 5-HT receptor antagonist ritanserin attenuated 5-HT effects on RBF, RVR, and GFR. Moreover, the serum and urinary COX-1 and COX-2 levels in 5-HT-treated piglets were unchanged compared with the control. These data suggest that activation of renal microvascular SMC TRPV4 channels by 5-HT impairs kidney function in neonatal pigs independently of COX production.
Xie Z, Peng S, Ou G, Zhou X, Zhang G, Jiang H Front Endocrinol (Lausanne). 2024; 15:1438373.
PMID: 39497801 PMC: 11532146. DOI: 10.3389/fendo.2024.1438373.
Milestone Papers on Signal Transduction Mechanisms of Hypertension and Its Complications.
Eguchi S, Torimoto K, Adebiyi A, Kanthakumar P, Bomfim G, Wenceslau C Hypertension. 2024; 81(5):977-990.
PMID: 38372140 PMC: 11023792. DOI: 10.1161/HYPERTENSIONAHA.123.21365.